X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (53664) 53664
Newsletter (2164) 2164
Newspaper Article (314) 314
Book / eBook (135) 135
Magazine Article (33) 33
Book Chapter (26) 26
Dissertation (22) 22
Reference (21) 21
Transcript (20) 20
Web Resource (18) 18
Publication (16) 16
Conference Proceeding (9) 9
Streaming Video (6) 6
Report (2) 2
Book Review (1) 1
Government Document (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (44597) 44597
oncology (22201) 22201
female (21203) 21203
animals (20035) 20035
cancer (19000) 19000
male (17951) 17951
pharmacology & pharmacy (14506) 14506
antineoplastic agents - therapeutic use (12828) 12828
chemotherapy (12227) 12227
middle aged (12034) 12034
antineoplastic agents - pharmacokinetics (11886) 11886
antineoplastic agents - pharmacology (11443) 11443
aged (10907) 10907
antineoplastic agents (10303) 10303
adult (10119) 10119
mice (9876) 9876
antineoplastic agents - administration & dosage (9577) 9577
antimitotic agents (9223) 9223
cell line, tumor (8770) 8770
neoplasms - drug therapy (8683) 8683
pharmacokinetics (8325) 8325
care and treatment (8164) 8164
research (7238) 7238
treatment outcome (7167) 7167
antineoplastic agents - adverse effects (6259) 6259
antineoplastic combined chemotherapy protocols - therapeutic use (6221) 6221
medicine & public health (5901) 5901
dose-response relationship, drug (5652) 5652
tumors (5603) 5603
analysis (5323) 5323
apoptosis (4951) 4951
drug therapy (4856) 4856
antineoplastic agents - chemistry (4748) 4748
therapy (4659) 4659
health aspects (4457) 4457
pharmacology/toxicology (4142) 4142
rats (4074) 4074
drugs (4018) 4018
drug delivery systems (3916) 3916
toxicity (3743) 3743
hematology (3732) 3732
breast neoplasms - drug therapy (3664) 3664
breast cancer (3575) 3575
in-vitro (3553) 3553
aged, 80 and over (3472) 3472
apoptosis - drug effects (3423) 3423
metastasis (3367) 3367
clinical trials (3318) 3318
expression (3263) 3263
nanoparticles (3254) 3254
paclitaxel (3203) 3203
mice, nude (3161) 3161
cisplatin (3141) 3141
cell proliferation - drug effects (3122) 3122
drug administration schedule (3079) 3079
cancer therapies (3045) 3045
antineoplastic combined chemotherapy protocols - adverse effects (3013) 3013
xenograft model antitumor assays (3000) 3000
doxorubicin (2986) 2986
biochemistry & molecular biology (2972) 2972
cell survival - drug effects (2967) 2967
tissue distribution (2953) 2953
pharmacology (2945) 2945
cells (2924) 2924
cancer research (2875) 2875
lung neoplasms - drug therapy (2728) 2728
clinical trials as topic (2602) 2602
neoplasms - metabolism (2599) 2599
cytotoxicity (2570) 2570
oncology, experimental (2539) 2539
drug resistance, neoplasm (2527) 2527
administration, oral (2512) 2512
breast-cancer (2499) 2499
chemistry, medicinal (2459) 2459
chemistry, multidisciplinary (2416) 2416
phase-i (2413) 2413
trial (2362) 2362
mice, inbred balb c (2350) 2350
dosage and administration (2341) 2341
medicine (2323) 2323
antitumor-activity (2322) 2322
antineoplastic agents, phytogenic - pharmacokinetics (2300) 2300
survival (2264) 2264
antineoplastic combined chemotherapy protocols - administration & dosage (2257) 2257
adolescent (2191) 2191
proteins (2168) 2168
phase-ii (2166) 2166
tumor cells, cultured (2164) 2164
prognosis (2131) 2131
neoplasms - pathology (2125) 2125
medical research (2091) 2091
in-vivo (2088) 2088
disease-free survival (2075) 2075
combination (2058) 2058
time factors (2055) 2055
leukemia (2046) 2046
area under curve (2032) 2032
carcinoma (2032) 2032
antineoplastic agents, phytogenic - administration & dosage (2008) 2008
solid tumors (1984) 1984
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (52) 52
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Chemistry (A D Allen) - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Periodical Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (55832) 55832
Japanese (512) 512
German (180) 180
Chinese (175) 175
French (171) 171
Russian (70) 70
Spanish (38) 38
Portuguese (26) 26
Polish (24) 24
Italian (22) 22
Norwegian (14) 14
Dutch (12) 12
Hungarian (11) 11
Czech (8) 8
Danish (8) 8
Swedish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Hebrew (2) 2
Serbian (2) 2
Finnish (1) 1
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


09/2000, Volume 39, Issue 3, 17
.... Pharmacokinetic studies provide differing data on renal function in obese... 
Beta adrenoceptor antagonists, pharmacokinetics | Bisoprolol, pharmacokinetics | Propranolol, pharmacokinetics | Gentamicin, pharmacokinetics | Dexfenfluramine, pharmacokinetics | Clinical pharmacokinetics | Nicotine, pharmacokinetics | Sotalol, pharmacokinetics | Antineoplastics, pharmacokinetics | Remifentanil, pharmacokinetics | Antihyperglycaemics, pharmacokinetics | Vecuronium bromide, pharmacokinetics | Theophylline, pharmacokinetics | Phenytoin, pharmacokinetics | Antibacterials, pharmacokinetics | Anaesthetics, pharmacokinetics | Doxorubicin, pharmacokinetics | Propofol, pharmacokinetics | Rocuronium bromide, pharmacokinetics | Anticonvulsants, pharmacokinetics | Carbamazepine, pharmacokinetics | Nebivolol, pharmacokinetics | Obesity | Sufentanil, pharmacokinetics | Vancomycin, pharmacokinetics | Anorectics, pharmacokinetics | Neuropsychotherapeutics, pharmacokinetics | Caffeine, pharmacokinetics | Interferon alpha, pharmacokinetics | Neuromuscular blocking agents, pharmacokinetics | Antifungals, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Xanthines, pharmacokinetics | Ciprofloxacin, pharmacokinetics | General anaesthesia | Glibenclamide, pharmacokinetics | Labetalol, pharmacokinetics | Busulfan, pharmacokinetics | Glipizide, pharmacokinetics | Ifosfamide, pharmacokinetics | Lithium, pharmacokinetics | Opioids, pharmacokinetics | Carboplatin, pharmacokinetics | Phenazone, pharmacokinetics | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | LEAN BODY-MASS | VANCOMYCIN | METABOLISM | NORMAL VOLUNTEERS | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | PATIENT | CLINICAL PHARMACOKINETICS | SIGNIFICANT WEIGHT-REDUCTION | CREATININE CLEARANCE | DISPOSITION | Adrenergic beta-Antagonists - pharmacokinetics | Anesthetics - pharmacokinetics | Anticonvulsants - pharmacokinetics | Hypoglycemic Agents - pharmacokinetics | Obesity - drug therapy | Antifungal Agents - pharmacokinetics | Humans | Anti-Bacterial Agents - pharmacokinetics | Antineoplastic Agents - pharmacokinetics | Obesity - metabolism
Book Review
International journal of pharmaceutics, ISSN 0378-5173, 02/2016, Volume 498, Issue 1-2, pp. 12 - 22
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2009, Volume 35, Issue 8, pp. 692 - 706
.... Post marketing study commitments have been made upon (accelerated) approval such as additional pharmacokinetic studies in patients with renal- or hepatic impairment... 
Hematology, Oncology and Palliative Medicine | Excretion | Absorption | Metabolism | Tyrosine kinase inhibitors | Distribution | Drug transporters and interactions | CHRONIC MYELOGENOUS LEUKEMIA | RENAL-CELL CARCINOMA | CHRONIC MYELOID-LEUKEMIA | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | CHRONIC MYELOCYTIC-LEUKEMIA | ADVANCED SOLID MALIGNANCIES | IMATINIB MESYLATE GLEEVEC | GASTROINTESTINAL STROMAL TUMORS | CEREBROSPINAL-FLUID PHARMACOKINETICS | CANCER RESISTANCE PROTEIN | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Pyrroles - pharmacokinetics | Humans | Cytochrome P-450 Enzyme System - metabolism | Pyridines - pharmacokinetics | Quinazolines - pharmacokinetics | Biological Availability | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Intestinal Absorption | Thiazoles - pharmacokinetics | Antineoplastic Agents - metabolism | Tissue Distribution | Benzenesulfonates - pharmacokinetics | Drug Interactions | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Dasatinib | Administration, Oral | Imatinib Mesylate | Protein Kinase Inhibitors - blood | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Agents - blood | Pyrimidines - pharmacokinetics | Indoles - pharmacokinetics | Protein Kinase Inhibitors - pharmacology | Benzamides | Protein Kinase Inhibitors - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Care and treatment | Oncology, Experimental | Cytochrome P-450 | Physiological aspects | Phenols | Research | Phosphotransferases | Protein binding | Cancer | Index Medicus
Journal Article
2003, Volume 42, Issue 14, 30
Modifications to bodily functions and physiology are known to occur with age. These changes can have a considerable impact on the pharmacokinetic processes... 
Melphalan, pharmacokinetics | Vinblastine, pharmacokinetics | Cytarabine, pharmacokinetics | Antimetabolites, pharmacokinetics | Gemcitabine, pharmacodynamics | Vinca alkaloids, pharmacodynamics | Fluorouracil, pharmacokinetics | Ifosfamide, pharmacodynamics | Methotrexate, pharmacokinetics | Topotecan, pharmacodynamics | Capecitabine, pharmacodynamics | Irinotecan, pharmacokinetics | Vinca alkaloids, pharmacokinetics | Alkylating agents, pharmacokinetics | Chlorambucil, pharmacokinetics | Cyclophosphamide, pharmacodynamics | Vincristine, pharmacokinetics | Carboplatin, pharmacodynamics | Fludarabine, pharmacodynamics | Cisplatin, pharmacokinetics | Vinorelbine, pharmacodynamics | Capecitabine, pharmacokinetics | Platinum complexes, pharmacokinetics | Topotecan, pharmacokinetics | Cytarabine, pharmacodynamics | DNA topoisomerase inhibitors, pharmacodynamics | Chlorambucil, pharmacodynamics | Fluorouracil, pharmacodynamics | Fludarabine, pharmacokinetics | Cyclophosphamide, pharmacokinetics | Antimetabolites, pharmacodynamics | Gemcitabine, pharmacokinetics | Melphalan, pharmacodynamics | Oxaliplatin, pharmacokinetics | Vinblastine, pharmacodynamics | Vinorelbine, pharmacokinetics | Cisplatin, pharmacodynamics | Vincristine, pharmacodynamics | Oxaliplatin, pharmacodynamics | Irinotecan, pharmacodynamics | Ifosfamide, pharmacokinetics | Methotrexate, pharmacodynamics | Alkylating agents, pharmacodynamics | Platinum complexes, pharmacodynamics | Carboplatin, pharmacokinetics | Elderly | DNA topoisomerase inhibitors, pharmacokinetics | Cancer | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | CELL LUNG-CANCER | LEUKEMIA GROUP-B | DOXORUBICIN-BASED CHEMOTHERAPY | COLONY-STIMULATING FACTOR | RANDOMIZED PHASE-III | METASTATIC BREAST-CANCER | NON-HODGKINS-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | PHARMACOLOGY & PHARMACY | ACUTE MYELOID-LEUKEMIA | PLASMA-PROTEIN BINDING | Drug Interactions | Antineoplastic Agents - adverse effects | Humans | Aged, 80 and over | Aging | Aged | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Frail Elderly | Patient Compliance | Neoplasms - drug therapy | Randomized Controlled Trials as Topic
Book Review
CPT: pharmacometrics and systems pharmacology, ISSN 2163-8306, 2017, Volume 6, Issue 9, pp. 576 - 588
Journal Article